Bone Biologics (BBLG) Consolidated Net Income (2010 - 2025)
Bone Biologics (BBLG) reported Consolidated Net Income of -$685141.0 for Q4 2025, up 55.36% year-over-year from -$441013.8 in Q4 2024, and down 2.57% quarter-over-quarter from -$667949.0 in Q3 2025.
Bone Biologics (BBLG) Consolidated Net Income (2010 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 16 years of Consolidated Net Income data on file, last reported at -$685141.0 in Q4 2025.
- Consolidated Net Income for Q4 2025 came in at -$685141.0, up 55.36% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.1 million (up 25.23% YoY), and the FY2025 annual result was -$3.1 million, up 25.23% from the prior year.
- Consolidated Net Income retreated to -$685141.0 in Q4 2025 per BBLG's latest filing, from -$667949.0 in the prior quarter.
- Over five years, Consolidated Net Income peaked at -$176137.0 in Q4 2021 and troughed at -$3.1 million in Q1 2023.
- A 5-year average of -$1.1 million and a median of -$848899.5 in 2024 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2024: Consolidated Net Income slumped 630.73% in 2022, then soared 73.86% in 2024.
- A 5-year view of Consolidated Net Income shows it stood at -$176137.0 in 2021, then tumbled by 630.73% to -$1.3 million in 2022, then gained by 9.9% to -$1.2 million in 2023, then slumped by 32.34% to -$1.5 million in 2024, then surged by 55.36% to -$685141.0 in 2025.
- Business Quant data shows BBLG's Consolidated Net Income at -$685141.0 in Q4 2025, -$667949.0 in Q3 2025, and -$741421.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 30.80 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.40 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -56.48 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | -685,141.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -685,141.00 |
| Sep 30, 2025 | -667,949.00 |
| Jun 30, 2025 | -741,421.00 |
| Mar 31, 2025 | -1.02 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Sep 30, 2024 | -931,028.00 |
| Jun 30, 2024 | -794,518.00 |
| Mar 31, 2024 | -903,281.00 |
| Dec 31, 2023 | -1.16 Mn |
| Sep 30, 2023 | -2.08 Mn |
| Jun 30, 2023 | -3.04 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -437,827.00 |
| Mar 31, 2022 | -689,499.00 |
| Dec 31, 2021 | -176,137.00 |
| Sep 30, 2021 | -509,303.00 |
| Jun 30, 2021 | -491,898.00 |
| Mar 31, 2021 | -431,747.00 |